(0.58%) 5 075.75 points
(0.33%) 38 194 points
(0.81%) 17 579 points
(0.67%) $79.53
(2.23%) $1.975
(-0.18%) $2 306.90
(-1.13%) $26.45
(0.37%) $958.40
(0.15%) $0.934
(0.51%) $11.09
(0.08%) $0.799
(-1.49%) $91.87
0.89% $ 0.759
Live Chart Being Loaded With Signals
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States...
Stats | |
---|---|
Volumen de hoy | 188 724 |
Volumen promedio | 626 109 |
Capitalización de mercado | 41.47M |
EPS | $0 ( 2024-03-04 ) |
Próxima fecha de ganancias | ( $-0.380 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.350 |
ATR14 | $0.00400 (0.53%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-05 | Goncalves Joana | Sell | 2 753 | Common Stock |
2024-04-05 | Terrillion Scott | Sell | 2 753 | Common Stock |
2024-02-29 | Terrillion Scott | Sell | 3 293 | Common Stock |
2024-02-29 | Posner Christopher | Sell | 5 834 | Common Stock |
2024-02-29 | Goncalves Joana | Sell | 3 293 | Common Stock |
INSIDER POWER |
---|
72.39 |
Last 96 transactions |
Buy: 1 992 546 | Sell: 375 720 |
Volumen Correlación
Cara Therapeutics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
AHCO | 0.982 |
MDRX | 0.978 |
TTEC | 0.974 |
TUEM | 0.973 |
UPLD | 0.972 |
APTX | 0.97 |
SSP | 0.969 |
OLPX | 0.964 |
MICS | 0.963 |
VERU | 0.961 |
10 Correlaciones Más Negativas | |
---|---|
CPTA | -0.959 |
XLRN | -0.958 |
FLMN | -0.955 |
ZGNX | -0.953 |
TIG | -0.952 |
ITI | -0.948 |
PPYAU | -0.948 |
RAM | -0.946 |
GPACU | -0.942 |
KTCC | -0.941 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cara Therapeutics Inc Correlación - Moneda/Commodity
Cara Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $20.97M |
Beneficio Bruto: | $14.54M (69.32 %) |
EPS: | $-2.19 |
FY | 2023 |
Ingresos: | $20.97M |
Beneficio Bruto: | $14.54M (69.32 %) |
EPS: | $-2.19 |
FY | 2022 |
Ingresos: | $41.87M |
Beneficio Bruto: | $34.60M (82.65 %) |
EPS: | $-1.550 |
FY | 2021 |
Ingresos: | $23.03M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.740 |
Financial Reports:
No articles found.
Cara Therapeutics Inc
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. Its product candidate includes Oral KORSUVA (difelikefalin), which has completed Phase II clinical trial to treat pruritus atopic dermatitis and pruritus non-dialysis-dependent chronic kidney disease (NDD-CKD) associated pruritus; and in Phase II clinical trial to treat pruritus chronic liver disease (CLD) primary biliary cholangitis (PBC) and notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico